ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Update

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the target of a large decline in short interest in March. As of March 15th, there was short interest totalling 367,200 shares, a decline of 22.1% from the February 28th total of 471,600 shares. Currently, 50.4% of the shares of the stock are sold short. Based on an average daily trading volume, of 1,090,000 shares, the days-to-cover ratio is currently 0.3 days.

ReShape Lifesciences Stock Performance

ReShape Lifesciences stock traded down $1.14 during mid-day trading on Wednesday, hitting $0.45. 73,769,031 shares of the company were exchanged, compared to its average volume of 1,674,976. The business has a fifty day moving average of $1.82 and a 200 day moving average of $4.14. ReShape Lifesciences has a 1-year low of $0.34 and a 1-year high of $29.00.

ReShape Lifesciences Company Profile

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.